Invention Grant
- Patent Title: Cell-controlled perfusion in continuous culture
-
Application No.: US15577415Application Date: 2016-05-27
-
Publication No.: US11597903B2Publication Date: 2023-03-07
- Inventor: Gregory Walter Hiller , Matthew Paul Gagnon , Ana Maria Ovalle
- Applicant: Boehringer Ingelheim International GmbH
- Applicant Address: DE Ingelheim am Rhein
- Assignee: Boehringer Ingelheim International GmbH
- Current Assignee: Boehringer Ingelheim International GmbH
- Current Assignee Address: DE Ingelheim am Rhein
- Agent Mary Breen Smith
- International Application: PCT/US2016/034570 WO 20160527
- International Announcement: WO2016/196261 WO 20161208
- Main IPC: C12N5/00
- IPC: C12N5/00 ; C12M1/00 ; C12M1/34

Abstract:
Methods of protein production in continuous perfusion mammalian cell culture bioreactors are provided. Methods for continuous perfusion culture by allowing cells to self-regulate the rate of addition of perfusion medium to the bioreactor via a pH change are presented. Compositions comprising the perfusion medium as well as the process advantages of using hi-end pH control of perfusion or HIPCOP are also presented.
Public/Granted literature
- US20180171279A1 CELL-CONTROLLED PERFUSION IN CONTINUOUS CULTURE Public/Granted day:2018-06-21
Information query